📣 VC round data is live. Check it out!

Clarent Valuation Multiples

Discover revenue and EBITDA valuation multiples for Clarent and similar public comparables like PMI Group, Brain+, Semantix, Premier Health Of America and more.

Clarent Overview

About Clarent

Clarent Corp operates under a liquidation plan of reorganization, which was confirmed by the bankruptcy court and became effective in April 2004.


Founded

1996

HQ

United States

Employees

850

Financials (FY)

Revenue:
Net Income:

EV

$492K

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Clarent Stock Performance

Clarent has current market cap of $492K, and enterprise value of $492K.


Clarent's stock price is $0.01.

See more trading valuation data for Clarent
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$492K$492K0.0%

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Clarent Valuation Multiples

Clarent Financial Valuation Multiples

As of May 10, 2026, Clarent has market cap of $492K and EV of $492K.

LTMLast FY202320242025202620272028

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Clarent Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Valuation Multiples Across 230+ Verticals

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
PMI Group
Brain+
Semantix0.0x(0.0x)
Premier Health Of America0.4x0.4x(12.5x)
Alternate Health
Monsenso1.6x(4.9x)
Telemedycyna Polska1.6x(7.3x)
Aino Health1.2x(13.0x)

This data is available for Pro users. Sign up to see all Clarent competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Clarent

When was Clarent founded?Clarent was founded in 1996.
Where is Clarent headquartered?Clarent is headquartered in United States.
How many employees does Clarent have?As of today, Clarent has over 850 employees.
Is Clarent publicly listed?Yes, Clarent is a public company listed on OTC Pink Sheets.
What is the stock symbol of Clarent?Clarent trades under CLRN ticker.
Who are competitors of Clarent?Clarent main competitors include PMI Group, Brain+, Semantix, Premier Health Of America, Alternate Health, Monsenso, Telemedycyna Polska, Aino Health, Comintelli, 1933 Industries.
What is the current market cap of Clarent?Clarent's current market cap is $492K.
Is Clarent profitable?No, Clarent is not profitable.
How many companies Clarent has acquired to date?Clarent hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Clarent has invested to date?Clarent hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Clarent

Lists including Clarent

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial